These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35080064)

  • 1. High-density lipoprotein lipid peroxidation as a diagnostics biomarker in coronary artery disease.
    Yazdandoust S; Parizadeh SMR; Ghayour-Mobarhan M; Yaghmaei P; Sahebkar AH
    Biofactors; 2022 May; 48(3):634-642. PubMed ID: 35080064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis.
    Kou T; Luo H; Yin L
    BMC Cardiovasc Disord; 2021 Mar; 21(1):127. PubMed ID: 33676400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in the association of the uric acid to high-density lipoprotein cholesterol ratio with coronary artery disease risk among Chinese nondialysis patients with CKD stages 3-5.
    Yang Y; Shen XY; Tang HX; Liu H; Wen Y
    Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1546-1553. PubMed ID: 38555242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Sensitivity C-Reactive Protein to HDL-C Ratio.
    Luo H; Kou T; Yin L
    Int Heart J; 2021 Nov; 62(6):1221-1229. PubMed ID: 34744148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations.
    Samadi S; Abolbashari S; Meshkat Z; Mohammadpour AH; Kelesidis T; Gholoobi A; Mehramiz M; Tabadkani M; Sadabadi F; Dalirfardouei R; Ferns GA; Ghayour-Mobarhan M; Avan A
    Biofactors; 2019 May; 45(3):374-380. PubMed ID: 30693992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population.
    Huang YC; Ho CC; Lin PT; Lee BJ; Lai CH; Liaw YP
    Nutr Res; 2010 Jan; 30(1):21-6. PubMed ID: 20116656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort.
    Samadi S; Mehramiz M; Kelesidis T; Mobarhan MG; Sahebkar AH; Esmaily H; Moohebati M; Farjami Z; Ferns GA; Mohammadpour AH; Avan A
    J Cell Physiol; 2019 Sep; 234(9):16168-16177. PubMed ID: 30784041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between monocyte to high-density lipoprotein cholesterol ratio and multi-vessel coronary artery disease: a cross-sectional study.
    Chen J; Wu K; Cao W; Shao J; Huang M
    Lipids Health Dis; 2023 Aug; 22(1):121. PubMed ID: 37553680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between neutrophil/lymphocyte ratio combined with low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with acute coronary syndrome].
    Yuan S; Pu T; Wang Z; Li L; Gao P; Zhang L; Ma Y; Qi Q; Fan X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Mar; 34(3):274-279. PubMed ID: 35574745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease.
    You J; Wang Z; Lu G; Chen Z
    Biomed Res Int; 2020; 2020():7146028. PubMed ID: 32219140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The associations among thoracic aortic atherosclerosis, coronary atherosclerosis and the function of high density lipoprotein.
    Takao M; Zhang B; Fan P; Nomoto J; Saku K
    Atherosclerosis; 2001 Dec; 159(2):407-16. PubMed ID: 11730821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease.
    Shiga Y; Miura S; Mitsutake R; Kawamura A; Uehara Y; Saku K
    J Atheroscler Thromb; 2010 Aug; 17(8):870-8. PubMed ID: 20467190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the remnant cholesterol to high-density lipoprotein cholesterol ratio and the risk of coronary artery disease.
    Pan L; Jiang W; Liao L; Li W; Wang F
    Coron Artery Dis; 2024 Mar; 35(2):114-121. PubMed ID: 38189652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oxidation ratio of LDL: a predictor for coronary artery disease.
    Huang H; Mai W; Liu D; Hao Y; Tao J; Dong Y
    Dis Markers; 2008; 24(6):341-9. PubMed ID: 18688083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: the Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan.
    Chang PY; Lee CM; Hsu HC; Lin HJ; Chien KL; Chen MF; Chen CH; Lee YT; Yang CY
    Lipids Health Dis; 2012 Nov; 11():162. PubMed ID: 23173569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.